Avoro Capital Advisors LLC Krystal Biotech, Inc. Transaction History

Avoro Capital Advisors LLC

$7.32 Billion
Q3 2025

A detailed history of Avoro Capital Advisors LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 2,777,777 shares of KRYS stock, worth $573 Million. This represents 6.7% of its overall portfolio holdings.

Number of Shares

2,777,777

Previous 2,660,000 4.43%

Holding current value

$573 Million

Previous $366 Million 34.11%

% of portfolio

6.7%

Previous 6.67%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$134.94 - $176.75 $15.9 Million - $20.8 Million	117,777 Added 4.43%	2,777,777 $490 Million
Q2 2025 Aug 14, 2025	SELL	$123.36 - $181.0 $8.76 Million - $12.9 Million	-71,000 Reduced 2.6%	2,660,000 $366 Million
Q1 2025 May 15, 2025	BUY	$142.64 - $194.44 $14.6 Million - $19.9 Million	102,178 Added 3.89%	2,731,000 $492 Million
Q4 2024 Feb 14, 2025	BUY	$156.64 - $199.61 $1.03 Million - $1.32 Million	6,600 Added 0.25%	2,628,822 $412 Million
Q3 2024 Nov 14, 2024	BUY	$174.7 - $213.66 $33.1 Million - $40.4 Million	189,222 Added 7.78%	2,622,222 $477 Million

Q2 2024 Aug 14, 2024	SELL	$153.12 - $183.64 $18.8 Million - $22.5 Million	-122,555 Reduced 4.8%	2,433,000 $447 Million
Q1 2024 May 15, 2024	SELL	$108.01 - $179.35 $1.08 Million - $1.79 Million	-10,000 Reduced 0.39%	2,555,555 $455 Million
Q3 2023 Nov 14, 2023	BUY	$108.51 - $130.22 $514,771 - $617,763	4,744 Added 0.19%	2,565,555 $298 Million
Q2 2023 Aug 14, 2023	BUY	$78.48 - $130.32 $63.6 Million - $106 Million	810,811 Added 46.33%	2,560,811 $301 Million
Q1 2023 May 15, 2023	BUY	$72.39 - $84.27 $24.6 Million - $28.7 Million	340,000 Added 24.11%	1,750,000 $140 Million
Q4 2022 Feb 14, 2023	BUY	$63.14 - $79.9 $8.52 Million - $10.8 Million	135,000 Added 10.59%	1,410,000 $112 Million
Q3 2022 Nov 14, 2022	BUY	$64.85 - $82.4 $13 Million - $16.5 Million	200,000 Added 18.6%	1,275,000 $88.9 Million
Q2 2022 Aug 15, 2022	BUY	$48.93 - $73.47 $3.43 Million - $5.14 Million	70,000 Added 6.97%	1,075,000 $70.6 Million
Q1 2022 May 16, 2022	BUY	$51.99 - $72.11 $27.6 Million - $38.2 Million	530,000 Added 111.58%	1,005,000 $66.9 Million
Q4 2021 Feb 14, 2022	BUY	$39.81 - $88.24 $18.9 Million - $41.9 Million	475,000 New	475,000 $33.2 Million

Others Institutions Holding KRYS

# of Institutions

325

Shares Held

25M

Call Options Held

241K

Put Options Held

625K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $5.29B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Account

Avoro Capital Advisors LLC Krystal Biotech, Inc. Transaction History